Vertex Provided Successful Results of VX-880 for Type 1 Diabetes Then Placed the Product on Clinical Hold

A lot is happening while the Stock Market is tanking and is finally being considered a Bear Market. Trading in this Market as it is now is more like gambling rather than trading. We are working hard towards evaluating our picked stocks and finding the possible time they might reach our new targets.  

In the meantime, Vertex's stock, which we believe is one of the most successful biotech firms in the stock market, is underperforming following upgrades, not downgrades, by many fair . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.